Trials / Not Yet Recruiting
Not Yet RecruitingNCT05827471
Clinical Study of QSOX1 as a Biomarker for Colon Cancer
Clinical Application of Sulfhydryl Oxidase QSOX1 as a New Biomarker of Colon Cancer
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Qianfoshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to determine whether the secreted protein QSOX1 can be used as a molecular marker for early rapid diagnosis and accurate treatment of colon cancer.
Detailed description
The project mainly selects the tumor group represented by colon cancer and the corresponding healthy people as the control group, with about 100 cases in each of the two groups. Mainly collect blood and tumor tissue samples of patients, detect the expression of QSOX1 in the above samples, and explore the role in the diagnosis and prognosis evaluation of colon cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diagnosis of colon cancer | Clinical diagnosis results |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
- First posted
- 2023-04-25
- Last updated
- 2023-04-25
Source: ClinicalTrials.gov record NCT05827471. Inclusion in this directory is not an endorsement.